Status:
UNKNOWN
Autonomic and Cardiovascular Recovery After the Acute Use of Resveratrol in Overweight and Obesity Individuals
Lead Sponsor:
Taisy Cinthia Ferro Cavalcante
Conditions:
Polyphenols
Cardiovascular Diseases
Eligibility:
All Genders
20-59 years
Phase:
NA
Brief Summary
The aim of this study is to understand the importance of resveratrol supplementation as a possible adjuvant in improving the metabolic profile and cardiovascular autonomic recovery of individuals with...
Detailed Description
Food is a strong ally in improving the metabolic state in overweight, obesity and prevention of associated diseases, working on weight loss and ingestion of anti-inflammatory, anti-oxidant and cardiop...
Eligibility Criteria
Inclusion
- \- Individuals with overweight and obesity grade I
Exclusion
- Cardiorespiratory disorders
- Neurological disorders
- skeletal muscle injury
- Known impairments that prevent the subject from performing the procedures.
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06020313
Start Date
August 1 2023
End Date
October 1 2023
Last Update
August 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taisy Cinthia Ferro Cavalcante
Petrolina, Pernambuco, Brazil, 56328-900